相似文献
1
Beefing up prostate cancer therapy with performance-enhancing (anti-) steroids.
Cancer Cell. 2011 Jul 12;20(1):7-9. doi: 10.1016/j.ccr.2011.06.019.
2
Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combination with prednisone.
Drugs Today (Barc). 2019 Jan;55(1):5-15. doi: 10.1358/dot.2019.55.1.2914339.
4
Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study.
Jpn J Clin Oncol. 2021 Apr 1;51(4):544-551. doi: 10.1093/jjco/hyaa225.
5
Anti-Androgen Abiraterone Acetate Improves the Therapeutic Efficacy of Statins on Castration-Resistant Prostate Cancer Cells.
J Oncol Res Ther. 2017;3(5). Epub 2017 Dec 20.
6
Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.
Lancet Oncol. 2018 Feb;19(2):194-206. doi: 10.1016/S1470-2045(17)30911-7. Epub 2018 Jan 8.
7
A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling.
Prostate. 2019 Jun;79(9):937-948. doi: 10.1002/pros.23799. Epub 2019 Apr 24.
8
Precision Medicine Approaches When Prostate Cancer Akts Up.
Clin Cancer Res. 2019 Feb 1;25(3):901-903. doi: 10.1158/1078-0432.CCR-18-2491. Epub 2018 Sep 11.
9
Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel.
Front Pharmacol. 2017 Nov 22;8:836. doi: 10.3389/fphar.2017.00836. eCollection 2017.
10
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
Lancet Oncol. 2019 May;20(5):686-700. doi: 10.1016/S1470-2045(19)30082-8. Epub 2019 Apr 12.
引用本文的文献
1
Efficient Everolimus Treatment for Metastatic Castration Resistant Prostate Cancer with Mutation: A Case Report.
Onco Targets Ther. 2021 Dec 8;14:5423-5428. doi: 10.2147/OTT.S334205. eCollection 2021.
2
Caspase control: protagonists of cancer cell apoptosis.
Exp Oncol. 2012 Oct;34(3):165-75.
3
The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way.
Prostate. 2013 Feb 15;73(3):267-77. doi: 10.1002/pros.22566. Epub 2012 Jul 20.
本文引用的文献
1
Abiraterone and increased survival in metastatic prostate cancer.
N Engl J Med. 2011 May 26;364(21):1995-2005. doi: 10.1056/NEJMoa1014618.
2
Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?
Clin Cancer Res. 2011 Jun 15;17(12):3858-64. doi: 10.1158/1078-0432.CCR-10-2044. Epub 2011 Mar 8.
3
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.
Nat Med. 2010 Jul;16(7):793-8. doi: 10.1038/nm.2166. Epub 2010 Jun 6.
4
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.
Lancet. 2010 Apr 24;375(9724):1437-46. doi: 10.1016/S0140-6736(10)60172-9. Epub 2010 Apr 14.
5
Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer.
J Natl Compr Canc Netw. 2010 Feb;8(2):211-23. doi: 10.6004/jnccn.2010.0014.
6
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.
J Clin Oncol. 2008 Jun 20;26(18):2959-65. doi: 10.1200/JCO.2007.15.1928.
7
Recurrent gene fusions in prostate cancer.
Nat Rev Cancer. 2008 Jul;8(7):497-511. doi: 10.1038/nrc2402. Epub 2008 Jun 19.
8
Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis.
J Clin Oncol. 2005 Nov 10;23(32):8253-61. doi: 10.1200/JCO.2005.03.4777.
9
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.
Cancer Res. 2004 Dec 15;64(24):9209-16. doi: 10.1158/0008-5472.CAN-04-2442.
Zotero 插件